Newsletter | November 5, 2024

11.05.24 -- Restoring Immune Homeostasis As A Development Approach To Treat And Modify Inflammatory Disease

FEATURED EDITORIAL

Restoring Immune Homeostasis As A Development Approach To Treat And Modify Inflammatory Disease

Drawing from experiences with ongoing work at AnaptysBio, Inc., senior VP of research Martin Dahl, Ph.D., shares three considerations when developing immune cell modulators to treat and modify inflammatory disease.

INDUSTRY INSIGHTS

Boost LNP Drug Potency With Optimized Delivery Formulations

Lipid nanoparticles (LNPs) function as a drug delivery system for nucleic acids. Learn about the biomedical applications of LNPs as well as the anatomy, formulation optimization, and safety of LNPs.

Extractables In Single-Use Systems Used In ADC Manufacturing

To address concerns about using organic solvents in the ADC process, extractables studies were conducted on a disposable chromatography column housing and two different disposable flow paths.

Two Steps Forward, One Step Back: IND Submission In Early Development

A panel of product development experts examines blind spots that can plague early development strategies, as well as important considerations when navigating the path toward an IND submission.

Continuous Flow Techniques For Fine Chemical Manufacturing

Explore the advantages and challenges of continuous flow processes and the concept of mini-monoplant technology, along with examples that demonstrate the versatility of continuous processing.

Designing Shelf-Stable, Dry Powder Vaccines To Improve Global Access

Spray dry technology is being leveraged to create shelf-stable, dry-powder vaccines to treat and prevent the spread of tuberculosis which could significantly improve our global response to disease.

Discovery Of Monoclonal Antibodies Against The SARS-CoV-2 Delta Spike Protein

Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.

MOST POPULAR NEWS

Transport Protein In Malaria Parasites Could Lead To Faster-Acting Medications

Sparrow Pharmaceuticals Completes Phase 2 Trial & FDA ODD Of Clofutriben

NeoMab Fully Human Antibody Discovery Platform

Qurient Launches Clinical Trial For Acute Myeloid Leukemia Treatment With Adrixetinib

Odyssey Therapeutics & Terray Therapeutics Enter Strategic Collaboration

Modalis Therapeutics Has Received An ODD From The U.S. FDA For MDL-101

ViaNautis Bio Signs Strategic Collaboration Agreement With Lilly

AI Computer Models May Make Development Of New Drugs Easier & More Cost-Effective

SPT Labtech & ICE Bioscience Launch Joint Automated Laboratory In China

Unique Multidomain Enzymes From Bacteria

Tyra Biosciences Receives IND Clearance From FDA To Proceed With Phase 2 Study Of TYRA-300

SOLUTIONS

Mechanistic Chromatography Modeling To Accelerate Process Development

Biocatalysis For Cost-Efficient, Environmentally Friendly Manufacturing

21 CFR Part 11 Compliance Checklist For A Universal Pump